- Home
- MRVL vs COR Comparison
MRVL vs COR Comparison
Compare MRVL & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRVL | COR |
|---|---|---|
| Founded | 1995 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.6B | 68.5B |
| IPO Year | 2020 | 2001 |
Fundamental Metrics
Financial Performance| Metric | MRVL | COR |
|---|---|---|
| Price | $80.39 | $366.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 30 | 13 |
| Target Price | $111.45 | ★ $395.23 |
| AVG Volume (30 Days) | ★ 10.7M | 1.2M |
| Earning Date | 03-02-2026 | 05-06-2026 |
| Dividend Yield | 0.30% | ★ 0.66% |
| EPS Growth | 5.56 | ★ 5.71 |
| EPS | 2.61 | ★ 2.87 |
| Revenue | $5,767,300,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $44.76 | $8.94 |
| Revenue Next Year | $22.29 | $6.79 |
| P/E Ratio | ★ $31.00 | $126.49 |
| Revenue Growth | 4.71 | ★ 9.31 |
| 52 Week Low | $47.09 | $248.59 |
| 52 Week High | $102.77 | $377.54 |
Technical Indicators
Market Signals| Indicator | MRVL | COR |
|---|---|---|
| Relative Strength Index (RSI) | 46.65 | 57.08 |
| Support Level | $69.08 | $331.73 |
| Resistance Level | $81.65 | $376.22 |
| Average True Range (ATR) | 3.03 | 8.30 |
| MACD | 0.25 | 0.35 |
| Stochastic Oscillator | 37.42 | 68.66 |
Price Performance
Historical ComparisonAbout MRVL Marvell Technology Inc.
Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.